Vivo Capital Fund VIII, L.P.

Director at TERN; 10% owner at CRNX

Sold, on record
$4.5M
Dollars the filings state
Form 4 sales
2
Latest Apr 7, 2020
Form 144 notices
2
Proposed sales
Companies
2
Filed as an executive or holder

Companies

  • TERNTerns Pharmaceuticals, Inc.Director
  • CRNXCrinetics Pharmaceuticals, Inc.10% owner

Sales by reason

0
Routine
1
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Timeline

  1. 1 Form 4 sale CRNXPlan not stated
    Feb 4, 2020 2020

    Sold 13,460 shares at $22.80 ($307k)

    Vivo Capital Fund VIII, L.P., 10% owner

    Sold 7% of holdings ($4.4M position)178,816 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale CRNXUnusual
    Apr 7, 2020 +63 days

    Sold 306,115 shares at $13.81 ($4.2M)

    Vivo Capital Fund VIII, L.P., 10% owner

    Sold 47.5% of holdings ($8.9M position)338,738 shares leftFiling

  3. 3 Form 144 notice TERNNotice
    Apr 1, 2024 +1455 days

    Filed to sell 63,956 shares ($455k)

    Vivo Capital Fund VIII, L.P., Director

    10b5-1 planFirst sale on recordFiling

  4. 4 Form 144 notice TERNNotice
    Apr 3, 2024 +2 days

    Filed to sell 39,416 shares ($236k)

    Vivo Capital Fund VIII, L.P., Director

    10b5-1 planFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Vivo Capital Fund VIII, L.P.
Source
Apr 3, 2024Apr 3, 2024TERNDirectorForm 144 notice39,416$236kNoticeSEC
Apr 1, 2024Apr 1, 2024TERNDirectorForm 144 notice63,956$455kNoticeSEC
Apr 7, 2020Apr 7, 2020CRNX10% ownerForm 4 sale306,115$4.2M47.5%UnusualSEC
Feb 4, 2020Feb 6, 2020CRNX10% ownerForm 4 sale13,460$307k7.0%Plan not statedSEC